Prudential Financial’s Alder Biopharmaceuticals ALDR Stock Holding History

Prudential Financial’s Portfolio ALDR Stock Details ALDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-140,890	Closed	-$2.93M	–	2400
2017 Q1	$2.93M	Buy	140,890 +22,500	+19%	+$498K	﹤0.01%	1372
2016 Q4	$2.46M	Buy	118,390 +25,390	+27%	+$660K	﹤0.01%	1439
2016 Q3	$3.05M	Sell	93,000 -3,500	-4%	-$107K	0.01%	1304
2016 Q2	$2.41M	Sell	96,500 -7,600	-7%	-$206K	﹤0.01%	1474
2016 Q1	$2.55M	Buy	104,100 +11,600	+13%	+$269K	﹤0.01%	1440
2015 Q4	$3.06M	Buy	92,500 +22,400	+32%	+$757K	0.01%	1308
2015 Q3	$2.3M	Buy	+70,100	New	+$2.98M	﹤0.01%	1393

Other funds holding ALDR

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

FCMI

Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Prudential Financial's ALDR Position: Q2 2017 in Review

Prudential Financial sold out of Alder Biopharmaceuticals (ALDR) in Q2 2017, closing a stake of 140,890 shares — an estimated $2.93M sold.

Prudential Financial first reported a position in ALDR in Q3 2015 and held it in 7 quarters. The position peaked at $3.06M in Q4 2015. 128 funds tracked by Wall St. Rank hold ALDR as of Q2 2017.

Prudential Financial reported no remaining Alder Biopharmaceuticals position as of Q2 2017 after selling out during the quarter.
Prudential Financial sold 140,890 Alder Biopharmaceuticals shares in Q2 2017, an estimated $2.93M.
Prudential Financial first reported a position in Alder Biopharmaceuticals in Q3 2015 and held it in 7 quarters.
Prudential Financial's Alder Biopharmaceuticals position peaked at $3.06M in Q4 2015.
128 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q2 2017.

Based on Prudential Financial's 13F filing for Q2 2017, filed 7 Aug 2017.